AIDD analysis
Automated Imaging Differentiation of Dementia
Differentiate between Alzheimer’s Disease (AD) and Dementia with Lewy Bodies (DLB). Built by experts. Backed by science. Designed for improving clinical outcomes.
How does AIDD work?
AIDD analyzes a diffusion MRI scan and provides a classification report that differentiates between two major types of dementia: AD and DLB.
Free-Water Imaging Analysis
AIDD analysis is based on Free-Water Imaging (FWI), which is a powerful enhancement to diffusion MRI scan processing techniques that separates true brain tissue signal from excess extracellular water.
Sharper microstructural insight
Measures severity, rate, and state of degeneration.
Earlier disease detection
Detects subtle microstructural changes between closer timepoints, beyond what volumetric imaging sees.
Improved differentiation between Alzheimer’s Disease and Dementia with Lewy Bodies.
Improves outcomes for healthcare and clinical trials.
96%
Up to 96% accuracy
21 sites
involved in most recent clinical trial
15+
Years of data collected
1000+
Unique datasets analyzed
Exclusive, Patented Technology
neuropacs™ leverages proprietary, patent-protected techniques that combine:
- AI-driven diagnostics trained on harmonized multi-site data
- Exclusively licensed with Patent pending.
- Free-Water Imaging (FWI): A powerful diffusion MRI method that enhances early disease detection
Comprehensive Toolset
Delivered via secure cloud-based workflow
Unmatched Accuracy
Up to 96% precision in distinguishing AD from DLB.
Whether supporting clinical decision-making or powering trial success, neuropacs™ provides exclusive methodologies, actionable insights, and a seamless integration into existing imaging workflows.
FAQs
Frequently asked questions
What MRI sequence can AIDD analyze?
Can I integrate AIDD into my existing PACS environment?
Ready to improve your outcomes using our precision AI platform?
Our dedicated team can help you determine which neuropacs™ solution best fits your clinical or research needs.